CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Net revenue	$ 59,088	$ 84,414	$ 191,578	$ 255,467
Cost of revenue	25,244	31,816	78,633	94,548
Gross profit	33,844	52,598	112,945	160,919
Sale of patents and other technology assets, net of costs (See Note 1)	0	0	116,353	0
Operating expenses:
Research and development	15,321	16,496	49,167	54,200
Sales and marketing	21,972	28,625	68,462	85,958
General and administrative	8,759	10,522	35,103	27,018
Restructuring and other charges	10,724	438	13,872	7,850
Loss (gain) on excess office facilities	243	0	243	(174)
Total operating expenses	57,019	56,081	166,847	174,852
Operating income (loss)	(23,175)	(3,483)	62,451	(13,933)
Other income (expenses):
Interest income, net	164	672	1,033	1,362
Gain (loss) on sale of equity and other investments, net	2,210	0	5,288	0
Equity in net loss of Rhapsody investment	(1,613)	(1,440)	(4,095)	(5,739)
Other income (expense), net	248	(228)	1,674	(661)
Total other income (expenses), net	1,009	(996)	3,900	(5,038)
Income (loss) before income taxes	(22,166)	(4,479)	66,351	(18,971)
Income tax benefit (expense)	(48)	(703)	(24,583)	(5,365)
Net income (loss)	(22,214)	(5,182)	41,768	(24,336)
Basic net income (loss) per share	$ (0.63)	$ (0.15)	$ 1.20	$ (0.71)
Diluted net income (loss) per share	$ (0.63)	$ (0.15)	$ 1.19	$ (0.71)
Shares used to compute basic net income (loss) per share	34,998	34,199	34,747	34,081
Shares used to compute diluted net income (loss) per share	34,998	34,199	35,000	34,081
Comprehensive income (loss):
Unrealized investment holding gains (losses), net of tax	5,407	12,401	1,840	11,014
Foreign currency translation gains (losses)	506	(4,335)	(1,730)	(425)
Total other comprehensive income (loss)	5,913	8,066	110	10,589
Net income (loss)	(22,214)	(5,182)	41,768	(24,336)
Comprehensive income (loss)	$ (16,301)	$ 2,884	$ 41,878	$ (13,747)